-+ 0.00%
-+ 0.00%
-+ 0.00%

ALTERITY THERAPEUTICS LTD - END-OF-PHASE 2 FDA MEETING REMAINS SCHEDULED FOR MID-2026

Reuters·04/27/2026 11:24:59

Please log in to view news